Moreover, approximately 96% of high-grade serous ovarian cancer (HGSOC), the most common and aggressive subtype of ovarian cancer, exhibits TP53 deletion and mutation [33], which implies that p53 disruption and reduced NAE1 expression may be associated with cancer progression. This evidence concerns the gene TP53 and ovarian cancer.